LncRNA VCAN‐AS1 serves as a diagnostic biomarker and drives pathogenesis in diabetic nephropathy via the miR‐205‐5p/VEGFA axis

20260 citationsJournal Article

Authors

Jing Zhou · Henan Provincial People's Hospital

Shasha Li · People's Hospital of Kaizhou District

Lingbo Lv · Shenzhen Second People's Hospital

Guoxia Luo · Fuling Center Hospital of Chongqing

Ning Xu · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Abstract

VCAN-AS1 serves as a potential diagnostic biomarker for DN and promotes disease pathogenesis through the miR-205-5p/VEGFA axis, highlighting its potential as a therapeutic target.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetic Medicine

DOI: 10.1111/dme.70259

Field-Weighted Citation Impact: 0.00